Tokyo, Jan. 31 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060518) titled 'Patient-Reported Outcome in Clinical practicE for Symptomatic-Stage Heart Failure registry' on Jan. 31.
Study Type:
Observational
Primary Sponsor:
Institute - Okayama University
Condition:
Condition - Symptomatic heart failure patients who are initially hospitalized
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To assess the cross-sectional and longitudinal association between patient background and indicators such as echocardiograms, cardiac MRI scans, and cardiac catheterization tests and each evaluation index of the KCCQ. In addition, to assess the association with subsequent hard outcomes by prospectively following up registered patients.
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients who presented with symptomatic first-time heart failure
Key exclusion criteria - Patients who were not able to give consent
Younger than 20 years old
Target Size - 1000
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 10 Month 15 Day
Date of IRB - 2025 Year 12 Month 12 Day
Anticipated trial start date - 2026 Year 02 Month 01 Day
Last follow-up date - 2029 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068702
Disclaimer: Curated by HT Syndication.
